Related Experiment Video
Updated: Jun 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Regulation of MCP-1 chemokine transcription by p53
Katrin Hacke1, Bladimiro Rincon-Orozco, Gilles Buchwalter
1Deutsches Krebsforschungszentrum, Forschungsschwerpunkt Infektion und Krebs, Abteilung Virale Transformationsmechanismen, Heidelberg, Germany.
Background:
Our previous studies showed that the expression of the monocyte-chemoattractant protein (MCP)-1, a chemokine, which triggers the infiltration and activation of cells of the monocyte-macrophage lineage, is abrogated in human papillomavirus (HPV)-positive premalignant and malignant cells. In silico analysis of the MCP-1 upstream region proposed a putative p53 binding side about 2.5 kb upstream of the transcriptional start. The aim of this study is to monitor a physiological role of p53 in this process.
Results:
The proposed p53 binding side could be confirmed in vitro by electrophoretic-mobility-shift assays and in vivo by chromatin immunoprecipitation. Moreover, the availability of p53 is apparently important for chemokine regulation, since TNF-alpha can induce MCP-1 only in human keratinocytes expressing the viral oncoprotein E7, but not in HPV16 E6 positive cells, where p53 becomes degraded. A general physiological role of p53 in MCP-1 regulation was further substantiated in HPV-negative cells harboring a temperature-sensitive mutant of p53 and in Li-Fraumeni cells, carrying a germ-line mutation of p53. In both cases, non-functional p53 leads to diminished MCP-1 transcription upon TNF-alpha treatment. In addition, siRNA directed against p53 decreased MCP-1 transcription after TNF-alpha addition, directly confirming a crosstalk between p53 and MCP-1.
Conclusion:
These data support the concept that p53 inactivation during carcinogenesis also affects immune surveillance by interfering with chemokine expression and in turn communication with cells of the immunological compartment.
Insights
The tumor suppressor p53 regulates monocyte chemoattractant protein-1 (MCP-1) expression, a key chemokine. Inactivation of p53 impairs immune surveillance by reducing MCP-1, impacting communication with immune cells.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Monocyte chemoattractant protein-1 (MCP-1) expression is reduced in human papillomavirus (HPV)-positive cancers.
- A potential p53 binding site was identified upstream of the MCP-1 gene.
Purpose of the Study:
- To investigate the physiological role of p53 in regulating MCP-1 expression.
Main Methods:
- Electrophoretic-mobility-shift assays (EMSA) and chromatin immunoprecipitation (ChIP) were used to confirm p53 binding.
- Experiments involved HPV-positive and negative keratinocytes, cells with mutated p53, and siRNA-mediated p53 knockdown.
Main Results:
- p53 binding to the MCP-1 promoter was confirmed in vitro and in vivo.
- TNF-alpha-induced MCP-1 expression requires functional p53; p53 degradation in HPV-positive cells abrogates this induction.
- Non-functional p53 in various cellular models led to diminished MCP-1 transcription.
Conclusions:
- p53 plays a crucial role in regulating MCP-1 chemokine expression.
- p53 inactivation during carcinogenesis impairs immune surveillance by affecting chemokine-mediated communication with immune cells.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Master Transcription Regulators
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

